Skip to content

Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMNAT1)

Homo sapiens — UniProt Q9HAN9

Gene: NMNAT1Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMNAT1) is a protein from Homo sapiens identified by UniProt accession Q9HAN9, 279 residues long. MolForge cross-references it against 0 known binders and 265 disease associations.

  • UniProt accession: Q9HAN9; gene symbol NMNAT1.
  • Organism: Homo sapiens.
  • Length: 279 amino acids.
  • Top disease associations (Open Targets): Leber congenital amaurosis 9, Leber congenital amaurosis and spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and leber congenital amaurosis.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameNicotinamide/nicotinic acid mononucleotide adenylyltransferase 1
UniProt accessionQ9HAN9
GeneNMNAT1
OrganismHomo sapiens
Length279 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (265)

Diseases linked to this target (Open Targets).

  • Leber congenital amaurosis 9 · score 0.81
  • Leber congenital amaurosis · score 0.67
  • spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and leber congenital amaurosis · score 0.58
  • Retinal dystrophy · score 0.52
  • Cone rod dystrophy · score 0.46
  • NMNAT1-related retinopathy · score 0.37
  • cone-rod dystrophy · score 0.34
  • Nystagmus · score 0.26
  • Global developmental delay · score 0.26
  • cone dystrophy · score 0.26

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9HAN9-F1alphafoldPREDICTED89.32—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9HAN9.

Amino-acid sequence (279 residues)

MENSEKTEVV LLACGSFNPI TNMHLRLFEL AKDYMNGTGR YTVVKGIISP VGDAYKKKGL IPAYHRVIMA ELATKNSKWV EVDTWESLQK EWKETLKVLR HHQEKLEASD CDHQQNSPTL ERPGRKRKWT ETQDSSQKKS LEPKTKAVPK VKLLCGADLL ESFAVPNLWK SEDITQIVAN YGLICVTRAG NDAQKFIYES DVLWKHRSNI HVVNEWIAND ISSTKIRRAL RRGQSIRYLV PDLVQEYIEK HNLYSSESED RNAGVILAPL QRNTAEAKT

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with NMNAT1?

The strongest Open Targets associations for NMNAT1 are Leber congenital amaurosis 9, Leber congenital amaurosis, spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and leber congenital amaurosis, Retinal dystrophy and Cone rod dystrophy.

How long is the NMNAT1 protein?

The Homo sapiens NMNAT1 protein (UniProt Q9HAN9) is 279 amino acids long.

Browse: Targets: N · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9HAN9
GeneNMNAT1
OrganismHomo sapiens
Length279
Binders0
Diseases265
View on UniProt